Local Institution - 410

Warsaw 00-739

0 studies enrolling now · 4 studies all time

What they study most

Crohn Disease, Multiple Sclerosis

Studies at this site

• Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease — Stopped early
• A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis — Completed